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RESUME: 
Contexte: 
L'objectif du présent travail de thèse est d'analyser rétrospectivement la série de 
méningiomes parasagittaux traités au CHUV, soit par traitements simples ou 
combinés (chirurgie et / ou radiochirurgie et radiothérapie fractionnée), afin de 
déterminer les facteurs qui influencent leur pronostic. 
Méthode: 
Entre Janvier 1999 et mai 2007, 37 méningiomes parasagittaux ont été traités dans 
notre centre. Nous avons analysé de manière rétrospective les différents paramètres 
du traitement de ces méningiomes ainsi que leur emplacement le long du sinus 
sagittal supérieur, leur volume, leur grade histologique et le degré de résection ainsi 
que le sexe et l'âge du patient afin de comprendre les facteurs qui influencent leur 
histoire naturelle. 
Résultats: 
Le suivi médian était de 6,7 ans (2,4 -12 ans). Les grades histologiques et le degré 
de résection tumorale (Simpson) étaient répartis uniformément le long du sinus 
sagittal supérieur. Le taux actuariel de contrôle global des tumeurs était de 65,9%. 
L'analyse de régression montre que le grade tumoral et le degré de résection sont 
deux facteurs extrêmement importants pour déterminer le contrôle tumoral (p <0,002 
et p <0,008). La localisation le long du sinus sagittal supérieur a montré une baisse 
du taux de contrôle dans le tiers postérieur (p <0,002). Le sexe, l'âge et le volume de 
la tumeur n'étaient quand à eux pas des facteurs significatifs. Par ailleurs, et de 
façon inattendue, dans notre série, la proportion du traitement adjuvant a été 
beaucoup plus élevée que dans les séries décrites jusqu'à maintenant (39% vs 7%) 
mais avec un taux de contrôle similaire et diminution de la morbidité et la mortalité. 
Conclusions: 
Dans notre série, le grade histologique et le degré de résection tumorale (Simpson) 
sont des facteurs indépendants de récidive et de contrôle tumoral. Fait intéressant, 
l'emplacement dans le tiers postérieur du sinus sagittal supérieur semble être un 
autre facteur indépendant de récidive. Afin d'éviter les morbidités importantes liées à 
la chirurgie nous préconisons une utilisation précoce de traitements adjuvants pour 
les tumeurs grade histologique élevé et pour les tumeurs situées dans la partie 
postérieure du sinus sagittal supérieur. 
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ABSTRACT: 
Background: 
The goal of the present study was to retrospectively analyze our series of parasagittal meningiomas, 
treated by either single or combined therapies (surgery and/or SRS and FSRT), in order to determine 
the factors that influence patient outcome. 
Methods: 
Between January 1999 and May 2007, 37 parasagittal meningiomas were treated in our center. We 
compared the outcome of the parasagittal meningiomas in relation to the treatment and adjuvant 
treatment given, their location along the SSS, their volume, their histological and resection grade as 
well as the patient's sex and age to understand which factors influenced their natural history. 
Findings: 
Median follow-up was 6.7 years (2.4 -12 years). Tumor grades and Simpson resection grade were 
distributed evenly along the SSS. The actuarial overall tumor contrai rate was 65.9 %. Regression 
analysis showed, that the tumor histological grade and the Simpson resection grade were two 
significant factors in determining the tumor contrai (p<0.002 and p<0.008). Location along the SSS 
showed a lower contrai rate in the posterior third (p<0.002). Sex, age and tumor volume, however, 
were not significant factors. Moreover, and unexpectedly, the ln our series, the proportion of adjuvant 
treatment was much higher than in former described series (39% vs 7%) but with similar contrai rate 
and lower morbidity and mortality. 
Conclusions: 
ln our series, histological grade and Simpson grade are independent factors for recurrence and tumor 
contrai. lnterestingly, location in the posterior third of the SSS seems to be another independent factor 
for recurrence. ln order to avoid major morbidities related to surgery we advocate earlier use of 
adjuvant therapies for higher histological grade tumors and for tumors located at the posterior portion 
of the SSS, but definitive conclusions might warrant a larger series. 
Key words: parasagittal meningiomas, neurosurgery, stereotactic radiosurgery, brain 
radiotherapy, tumor contrai, prognosic factors 
Abbreviations: 
FSRT: fractionated stereotactic radiotherapy 
SD: standard deviation 
SRS: stereotactic radiosurgery 
SSS: superior sagittal sinus 
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INTRODUCTION: 
Meningiomas represent 15 to 20% of all primary intracranial tumors. Most of them 
are benign tumors and can be cured if completely resected. Surgery is the gold 
standard treatment for the majority of meningiomas, and has been proven to be the 
best way to achieve tumor contrai if the tumor is completely removed together with 
any durai involvement (18). However, stereotactic radiosurgery and fractionated 
stereotactic radiotherapy are alternative therapeutic strategies when the 
meningiomas are located in delicate areas or in the case of recurrences. lndeed, 
tumors associated with significant surgical risks are those located close to vascular 
structures or cranial nerves. Among them, parasagittal meningiomas are challenging 
tumors due to their anatomie relation to the SSS. These tumors were defined by 
Cushing and Eisenhardt (7) as those that fill the parasagittal angle, with no brain 
tissue between the tumor and the SSS. Their intimate relation with the SSS and with 
critical bridging veins poses a risk for catastrophic complications. Their tendency of 
invading the SSS adds another challenge for the surgical resection. lt is therefore 
necessary to find the right balance between aggressive surgical resection and the 
risk of complications (17). ln our center, a multidisciplinary approach was preferred 
over aggressive surgical treatment for these tumors. 
Parasagittal meningiomas comprise between 17 and 31 % of intracranial 
meningiomas (3, 5-7, 11, 13, 21, 22). Their distribution along the SSS has already 
been reported to range from 14.8% to 33.9% in the anterior third, 44.8% to 70.4% in 
the middle third, and 9.2% to 29.6% in the posterior third of the sinus respectively (6, 
7, 9-11, 17). Despite the improvement in the imaging of these tumors, the 
involvement of the SSS and surrounding veins make these tumors hard to remove 
completely, thus their management represents a real challenge due to the relatively 
high mortality and morbidity. Their rate of recurrence remains high despite the routine 
use of microsurgery and adjuvant therapy, and previous studies have shown that 
they tend to recur more often than meningiomas in other locations (4, 16). 
The aim of the present retrospective study is to analyze factors that influence the 
outcome of patients treated for parasagittal meningiomas at the Departments of 
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Neurosurgery and Radiation Oncology at the Centre Hospitalier Universitaire 
Vaudois (CHUV), in Lausanne, Switzerland. 
MATERIAL AND METHODS: 
Patients 
A total of 225 patients were treated for intracranial meningiomas in our center 
between January 1999 and December 2007. Among them, 37 parasagittal 
meningiomas, including two patients with multiple meningiomas, were treated. 
Patients with neurofibromatosis were excluded, although representing 9 parasagittal 
meningiomas. Therefore a total of 28 parasagittal meningiomas were included in our 
series. Patient data, including surgical records, discharge letters, histological records, 
follow-up records and MR imaging studies were analyzed retrospectively. Patients 
with multiple meningiomas were of similar age and sex distribution as the overall 
population. Follow-up MR imaging studies were obtained at 3 and 9 months and then 
annually. Moreover, each patient was clinically evaluated 6 weeks after surgery and 
then following each MR imaging. Median follow up was 6.7 years (2.4 - 12 years). No 
patient was lost during follow-up. 
Treatments 
As a primary treatment, surgery was the first line of treatment for all patients for 
meningiomas over 1cm diameter or 0.5cm3 . Tumor exposure and removal were 
performed with standard microsurgical techniques. ln patients with complete SSS 
obliteration in the anterior third of the SSS (2/28) (Sindou grade Type V and VI (19, 
20)), ligation and section of the proximal and distal ends of the sinus allowed an "en 
bloc" removal of the tumor. No attempt at complete sinus resection followed by 
reconstruction was performed when the tumor was placed in the posterior two thirds 
of the SSS. A durai patch was then used to reconstruct the dura and the bone flap 
was then fixed to the cranium using low profile titanium mini plates. The extension of 
the resection was assessed during surgery and with a postoperative MRI. 
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Stereotactic Radiosurgery (SRS) and Fractionated Stereotactic Radiotherapy (FSRT) 
were performed using a 6-MV photon beam provided by a Primus linear accelerator 
(Siemens®, USA) and a micromultileaf collimator with 3 mm width leaves at isocenter 
(Brainlab®, Germany). 
SRS was performed for meningiomas under 1 cm as a first intention treatment in 
case of symptomatic meningiomas or radiological proof of progression (2 patients). 
SRS was also a second intention therapy for recurrences or residual tumor under 3 
cm (7 patients) [Figure 1]. Patient immobilization and target volume definition was 
achieved using the Radionic stereotactic frame (lntegra®, USA). After fixation of the 
stereotactic frame under local anesthesia, a three-dimensional CT data cube 
generated from continuous 2-mm CT scan slices was performed and was then fused 
with a previous non-stereotactic MPRAGE gadolinium MRI. When the size was under 
1 cm, a dose of 18 Gy at the isodose 80% was delivered in a single fraction. For 
meningiomas between 1 and 3 cm, a dose of 16 Gy at the isodose 80% was 
delivered a single fraction. 
FRST was used for the same indications as for SRS but for meningiomas larger than 
3 cm. Patients were immobilized using a commercially available stereotactic mask 
(BrainLAB® Mask System) made of thermo-plast material. The main goal of 
treatment planning was complete coverage of the tumor volume with the prescribed 
dose and maximal dose limitation to adjacent critical structures. A median dose of 
54.6 Gy (range 50.4 Gy - 60 Gy) at the isocenter was delivered, with a dose of 1.8 
Gy per fraction, an a median of 31 fractions. 
Statistics 
A regression analysis was performed examining the influence of sex, age, Simpson 
resection grade, tumor size, tumor location, type of treatments and adjuvant 
treatment received and tumor histology at diagnosis. Recurrence-free survival rates 
(calculated from date of first treatment to date of first recurrence, or last follow-up in 
patients with no recurrence) were estimated with the Kaplan-Meier method. 
Additional comparisons used Student T-tests and Chi-square tests as appropriate. 
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RESULTS: 
Epidemiology 
There were 14 females (50%) and 14 males, with a mean age at diagnosis of 54.8 ± 
13 years. Tumor volumes ranged from 0.5 cm3 to 113 cm3 , with a median volume of 
13.4 cm3 (0.5-113 cm3). The location along the SSS was: 8 (28.5%) in the first 
anterior third, 11 (39.2%) in the middle third and 9 (32.1 %) in the posterior third. 
There was no significant difference in the location for sex and age. [Table 1] 
Treatments 
Two patients had SRS as their sole treatment due to their meningioma size (O. 76 cm 
and 0.75 cm). The other twenty-six patients underwent surgery as the first treatment. 
Among these, fifteen patients had surgery only (53.57%) and eleven (39.2%) had an 
adjuvant treatment. Recurrence, as defined by reappearance of a meningioma on 
MR imaging in the same location as the previously treated and completely removed 
meningioma, occurred in 8 patients and progression, as defined by progression of a 
residual tumor on MR imaging, happened in 3 patients who had subtotal resection. 
Surgery was proposed as a second-intent treatment in our series for two patients 
with incomplete resection and re-growth that necessitated a second surgery; bath 
had histological grade progression and will be discussed below. Radiosurgery was 
performed in two cases after incomplete surgery with progression during follow-up 
and in four cases of recurrence. Three patients had fractionated stereotactic 
radiotherapy for recurrence (2) or subtotal surgery with progression (1 ). Two patients 
had bath radiosurgery and fractionated stereotactic radiotherapy for recurrence. 
These data are summarized in [Figure 1 ]. 
Simpson grades 
Simpson grade of resection was determined for the 26 patients who underwent 
surgery. Two patients had complete anterior third SSS obliteration with "en bloc" 
removal of the parasagittal meningioma and of the invaded sinus. ln our series, 
location along the SSS was nota determining factor for Simpson grade of resection. 
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The resection grade in the anterior third of the sinus was: Simpson 1 in seven patients 
and Simpson IV for one patient. ln the middle third of the sinus, the distribution was 
three Simpson 1, seven Simpson Il and one Simpson Ill respectively. Finally, in the 
posterior third of the SSS there were two Simpson 1, one Simpson Il, three Simpson 
Ill and one Simpson IV respectively. There was no statistically significant difference 
(p=0.20) in the Simpson grade along the SSS. [Table 2] 
Histological grades 
According to the WHO classification ( 14 ), 18 patients presented grade 1 (benign) 
meningiomas (7 transitional, 5 meningothelial, 4 fibroblastic, 1 angiomatous, 1 
mixed), 6 had grade Il (atypical) and 2 had grade Ill meningiomas. ln 2 patients 
treated with radiosurgery only, histological grade was not available. Their distribution 
along the SSS is summarized in [Table 2]. Here again, there was no statistically 
significant difference of histological grade distribution along the SSS (p<0.09) but 
males in our series tended to present higher grade lesions than women (p<0.01 ). 
Age and tumor size were not related to the histological grades (p=0.39 and 0.32 
respectively). 
Two patients had a histological progression during the course of their disease. The 
first patient was 34 years old when he presented a second third SSS, frontal 
parasagittal meningioma with partial sinus obliteration. Partial resection was 
performed in 1999 and the histology was that of a grade 1 meningioma. Three years 
later, the follow-up showed growth of the residual tumor motivating a second surgery. 
The histology then demonstrated an atypical meningioma with a high mitotic rate and 
it was decided therefore to perform radiosurgery on the 1.2cm residual tumor that 
could not be resected during the second surgery. The second patient presented at 
the age of 65 with a posterior third SSS parasagittal meningioma. He had a first 
incomplete resection due to the partial sinus obliteration. The histology at that time 
was that of a menigiomatous WHO grade 1 meningioma. Two years later, he 
presented with headaches and was found to have a recurrent 3 cm mass. A second 
surgery was performed and histology showed an atypical meningioma with a high 
mitotic rate. The residual tumor was 0.9 cm and the patient was treated with 
radiosurgery. 
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Tumor control 
When defining the failure of tumor contrai either by radiological demonstration of 
tumor growth or by the need of adjuvant treatment for clinical or radiological reasons, 
the multivariate regression analysis showed that tumor histological grade and 
Simpson resection grade were significant factors in determining the tumor contrai 
(p<0.002 and p<0.008 respectively), but that the other factors (tumor size (p=0.09), 
sex (p=0.1) and age (p=0.4 )) were not. A chi square analysis supports this [Table 3]: 
89% of WHO grade 1 meningiomas were controlled by treatment, decreasing to 33% 
for WHO grade Il meningiomas and none of the malignant lesions were controlled in 
our series; 92% of Simpson grade 1 were controlled, decreasing to 0% with grade IV. 
ln our series, considering that the two smaller meningiomas were treated by 
radiosurgery only and that their histology was not available, we could not determine 
within this small group if radiosurgery as the sole treatment was better, or as efficient 
for tumor contrai as surgery. Surprisingly, a segmentation of the SSS in three thirds 
shows that posterior location is a factor of worse prognosis in terms of recurrence 
and progression when compared to the two anterior thirds (p<0.002). 
Reflecting the impact of censored observations, actuarial contrai rates were less 
good but show the same trend. The 5-year actuarial overall tumor contrai rate for the 
entire se ries was 65.87 % +/- 0.10 [Figure 2a]. For patients who underwent 
radiosurgery (n=2) or surgery (n=15) as unique treatment, the actuarial 5-year contrai 
rate was 100%. Those who underwent surgery as a primary treatment, followed by 
radiosurgery as adjuvant treatment, had an actuarial 5-year contrai rate of 45.35 %. 
The contrai rate was even lower for those who had fractionated stereotactic 
radiotherapy as adjuvant treatment (14.96 %). 
The factors that influenced negatively the tumor contrai in our series were the high 
Simpson resection grade, the high histological grade as well as, more surprisingly, 
the posterior location of the meningioma along the SSS. 
lndeed, Simpson resection grade had an impact on the tumor contrai rate, Simpson 
grades 1 had a 5-year contrai rate of 86 % and higher Simpson grades had an 
overall contrai rate of 47 % (Log-rank test P=0.001) [Figure 2b]. 
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Moreover, the 5-year actuarial contrai rate for typical meningiomas was 89% and 
33% for atypical meningiomas. The malignant meningiomas had all progressed by 19 
months (Log-rank test P=0.001) [Figure 2c]. 
Furthermore, there was a trend toward a lower tumor contrai for meningiomas 
located in the posterior portion of the SSS (5-year contrai actuarial contrai rate was 
37.5% in the last third, 80% and 90% for the first and second third respectively) (Log-
rank test P=0.07) [Figure 2d]. 
Although sex was not a statistically significant parameter of tumor contrai (p<0.16), 
there was also a trend toward better tumor contrai in females. 
Clinical outcome 
Most of the patients tolerated their treatment well and their clinical status was either 
stable (57%) or improved (28% ). Two patients had a transient neurological worsening 
of their clinical status after surgery with a transient hemiparesis that resolved within a 
few days for one patient and within a few weeks for the other. Bath had frontal 
parasagittal meningioma located at the second third of the SSS. Four patients (14%) 
had a worsening of their clinical status, either transient due to surgical complication 
(wound infection and epidural hematoma) in two patients or progressive due to their 
high grade meningioma progression. Seven patients had a complication related to 
their treatment. One was due to radiosurgery with the formation of a post actinie 
cystic lesion of 2cm in a non-eloquent region, and two were indirectly related to 
surgery: 1 pulmonary embolism and 1 superficial thrombophlebitis. 
DISCUSSION: 
Epidemiology 
ln our series, 28 (12.4%) of 225 patients with a radiological diagnosis of intracranial 
meningioma had parasagittal meningioma. We excluded from our study 9 (4%) 
parasagittal meningiomas associated with neurofibromatosis since their genetic 
behavior is different. The parasagittal meningiomas in our series reprensent 16.4% of 
operated meningiomas, which is a little below their ratio found in the literature (17-
11 
31 %) (3, 5-7, 11, 13, 21, 22). The gender distribution was also somewhat different 
from that of other larger se ries (6, 8, 15) with a female to male ratio was 1: 1. 
lnterestingly, we have noted that men had higher grade meningiomas than women, 
which corraborates the description made in other larger studies (6). 
Tumor contrai and recurrence 
Previous studies have shown that parasagittal meningiomas are known to recur more 
often compared to those found in other locations (4, 16). The aim of this paper was 
to evaluate the factors that could influence this different behavior. Complete surgical 
removal together with any durai involvement, which is praven to be the best way to 
achieve tumor contrai, is often not possible due to the close relation between the 
meningiomas and the SSS. 
Tumor contrai is in itself difficult to define since radiological grawth contrai is not 
sufficient in assessing the clinical outcome. Therefore, we combined the results of 
grawth demonstrated on the radiological follow up and the need for adjuvant 
treatment, either for clinical or radiological reasons. Many studies have used simple 
percentages of these results but an actuarial calculation based on the length of 
follow-up seems to be mandatory for these slow grawing tumors. A limitation of this 
is, of course, that events can occur after a large number of patients have been 
censored and might have an excessive effect on the final percentage of contrai rate, 
and therefore we chose a 5-year actuarial contrai rate. 
ln the present study, the contrai rate could not be predicted by the tumor volume at 
the time of diagnosis. This observation is in contrast to a former study (15) in which a 
tumor volume greater than 13.4 cm3 (which was the median volume) was correlated 
with higher recurrence rates. ln our series, there was a strong trend toward lower 
contrai for bigger tumors but due to the smaller number of meningiomas analyzed in 
our series, this trend was not statistically significant. 
Moreover, compared to the study performed by Colli et al where the female gender 
was a predictive factor for better tumor contrai rate (6), the female gender, in our 
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series, was not considered as an independent predictive factor since women had 
histologically less aggressive menigiomas, which was per se the strongest predictive 
factor for tumor contrai. 
Most authors agree that recurrence rates for patients with atypical or malignant 
meningiomas is higher than for patients with WHO grade 1 (6, 8). ln our series, 
histological grade was also the main determinant of tumor contrai. No patient with a 
malignant meningioma had a tumor contrai longer than two years. 
lnterestingly, we report for the first time that the posterior site of implantation along 
the SSS seems to be another independent factor for a worse tumor contrai. This 
observation was never reported previously (6, 8). The segmentation of the SSS and 
the survival curves between anterior, middle and posterior thirds were never 
analyzed separately. One hypothesis is that a complete resection is more difficult in 
the posterior two thirds of the SSS, due to the intimate relationship between the 
tumor and the venous sinus or the critical bridging veins, and due to the increased 
morbidity in aggressive surgical management in areas of critical brain cortex. The 
abundant venous drainage in the posterior third of the SSS makes a complete 
removal more difficult than in other locations, leading therefore to a higher recurrence 
rate. However, these results need to be interpreted cautiously due to the small 
sample size of the present study and may warrant further studies. 
Finally, the most obvious cause of inability to reach tumor contrai is the failure to 
achieve radical resection of the meningioma, which is challenging for parasagittal 
locations. ln our series, Simpson grade was a statistically significant factor for tumor 
contrai, which corroborates former studies (1, 8, 12). Only 38% of the patients had a 
Simpson 1 resection with a tumor contrai of 90%. The higher Simpson grades were 
associated with tumor contrai rates below 66%. Altogether, 39% of our patients 
needed adjuvant therapy with similar results to the series focused on parasagittal 
meningiomas (15). Two patients with small parasagittal menigiomas underwent SRS 
only, with no tumor progression. SRS as the first treatment should be considered for 
small parasagittal menigiomas, when complete resection is associated with high 
morbidity. Nevertheless surgery remains the gold standard procedure for large 
parasagittal meningiomas and a complete removal should be attempted. 
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Mortality and Morbidity 
Operative mortality for resection of parasagittal meningiomas was formerly reported 
to range between 1.8% and 7.3%. This has decreased with the use of microsurgical 
techniques. lt has been asserted that complete sinus occlusion allows an en bloc 
removal of the tumor without significant risk (2, 8, 21 ). This was confirmed in our 
series. ln fact, we only performed a sinus resection in two patients with complete 
sinus obstruction and no mortality was observed. 
Morbidity, however, remains higher than for other locations. Transient neurological 
worsening happened in two patients (7.14%) in the immediate postoperative period 
and were bath related to second third SSS location. This has already previously been 
described (8) and the authors speculate that this transient impairment was caused by 
venous engorgement and difficulties in venous drainage caused either by sinus 
stenosis or lesions to collateral veins. The normal conditions of venous drainage are 
probably restored by the opening of alternative venous outflow pathways leading to 
neurological recovery. 
Other complications were not related to the location along the SSS, and most of them 
were in close relation to surgery and are comparable with other studies: 3 wound 
infections (10,7 %), one (3%) epidural hematoma, one deep venous thrombosis and 
one pulmonary embolism. Radiosurgery had very low morbidity since only one 
patient (7.9%) had an asymptomatic post-actinic cystic lesion. 
Compared to other centers, we tend to be less aggressive in the surgical 
management of meningiomas with partially invaded SSS. The proportion of adjuvant 
treatment (39%) is higher than in other series (7%) (8). Nevertheless tumor contrai 
based on the recurrence rate described in other series is comparable (71.4% in our 
series). Morbidity and mortality were somewhat lower in our series. 
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CONCLUSIONS: 
Tumor contrai in parasagittal meningiomas is challenging. ln our series, we 
confirmed the already well-known fact that histological grade and Simpson grade 
were two independent and strang factors for recurrence and tumor contrai, but sexe 
and size were not independent pragnosis factors in our series. lnterestingly, we 
noted that the posterior location along the SSS might as well be a bad pragnosis 
factor and is reported here for the first time. Due to the small number of cases 
treated, it may warrant further larger studies. ln our center, we tend to manage 
surgically the parasagittal meningiomas less aggressively, compared to other 
centers, but with an increased use of RSR and FRST as adjuvant treatments; we 
reach adequate tumor contrai with lower morbidity and mortality. The practical 
consequences might be earlier use of adjuvant therapies for higher histological grade 
tumors and for tumors located at the last portion of the SSS, and even consider SRS 
as a first treatment for small posterior meningiomas. 
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Tables: 
Parameter No.(%) 
Age [years] 
Median 54.8 
Range 29-84 
Sex 
Fern ale 14 (50) 
Male 14 (50) 
Tumor volume [cm3] 
Median 13.40 
Range 0.57-113 
Tumor location along the SSS 
First third 8 (28.5) 
Second third 11 (39.3) 
Last third 9 (32.1) 
Follow-up [months] 
Median 80 
Range 30-133 
Table 1: Patient population and tumor characteristics 
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Location along SSS No. (%) 
1 st third 2nd third 3rd third Total 
Simpson Grade 
Simpson grade 1 7 (26.92) 3 (11.54) 2 (7.69) 12 (46.15) 
Simpson grade Il 0 7 (26.92) 1 (3.85) 8 (30. 77) 
Simpson grade Ill 0 1 (3.85) 3 (11.54) 4 (15.38) 
Simpson grade IV 1 (3.85) 0 1 (3.85) 2 (7.69) 
WHO Grade 
WHO Grade 1 7 (26.92) 8 (30.77) 3 (11.54) 18 (69.23) 
WHO Grade Il 0 3 (11.54) 3 (11.54) 6 (23.08) 
WHO Grade Ill 1 (3.85) 0 1 (3.85) 2 (7.69) 
Table 2: Simpson grade and WHO grade distribution along SSS 
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Tumoral contrai No. (%) 
Controlled Non controlled p value 
Histological grade < 0.002 
WHO grade 1 16 (89) 2 
WHO grade Il 2 (33) 4 
WHO grade Ill 0 2 
Simpson grade < 0.008 
Simpson grade 1 11 (92) 1 
Simpson grade Il 6 (75) 2 
Simpson grade Ill 1 (25) 3 
Simpson grade IV 0 2 
Location along the SSS < 0.002 
1 st third 6 (75) 2 
2nd third 11 (92) 
3rd third 3 (37) 5 
Table 3: Tumor histological grade and Simpson grade as the most significant factors for tumor contrai 
(p<0.002 and p<0.008) respectively. ln our series, 3rd third SSS location is also a bad prognosis factor 
for progression / recurrence (p<0.002) 
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Fig. 2 Kaplan-Meier curves for recurrence-free survival in patients with parasagittal meningiomas. a 
Recurrence-free survival rate in all 28 meningiomas b Recurrence-free survival rates for different 
Simpson grades. Progression-free survival rates differed significantly between groups by log-rank test 
(P=0.001) c Recurrence-free survival rate significantly differs between meningiomas grades by log-
rank test (P=0.001) d Recurrence-free survival rate shows a trend toward a lower contrai in 3rd third 
parasagittal meningioma (log-rank test P=0.07). 
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